Bladder Outflow Obstruction Caused by Prostatic Calculi by R. Calleja, R. Yassari, E.P. Wilkinson, R. Webb

Get full text

Cellular Plasticity in Prostate Cancer Bone Metastasis by Dima Y. Jadaan, Mutaz M. Jadaan, John P. McCabe

“…Prostate Cancer…”
Get full text

Stauffer’s Syndrome in Patient with Metastatic Prostate Cancer by Andris Romašovs, Aldis Puķītis, Viktorija Mokricka, Elina Frolova

“…In literature cholestasis as manifestation of paraneoplastic syndrome has also been described in patients with prostate adenocarcinoma and pancreatic and bronchogenic carcinoma. …”
Get full text

Distribution of Neuroendocrine Cells in the Transition Zone of the Prostate by Yuki Kyoda, Koji Ichihara, Kohei Hashimoto, Ko Kobayashi, Fumimasa Fukuta, Naoya Masumori

“…To evaluate the distribution of neuroendocrine (NE) cells which may influence the development of benign prostatic hyperplasia (BPH) in the transition zone (TZ). …”
Get full text

Oxidative Stress and DNA Methylation in Prostate Cancer by Krishna Vanaja Donkena, Charles Y. F. Young, Donald J. Tindall

“…The protective effects of fruits, vegetables, and other foods on prostate cancer may be due to their antioxidant properties. …”
Get full text

Calcium Activation of the Androgen Receptor in Prostate Cells by Zeina W. Sharawi, Sawsan M. Khatrawi, Qiaochu Wang, Hongzhao Zhou, Kedra Cyrus, Gai Yan, Becky Hoxter, Bassem R. Haddad, Mary Beth Martin

“…Background. Although prostate cancer patients initially respond to androgen deprivation therapy, most patients progress to a resistant phenotype. …”
Get full text

XMRV Discovery and Prostate Cancer-Related Research by David E. Kang, Michael C. Lee, Jaydip Das Gupta, Eric A. Klein, Robert H. Silverman

“…XMRV infects and replicates well in many human cell lines, but especially in certain prostate cancer cell lines. XMRV also traffics to prostate in a nonhuman primate model of infection. …”
Get full text

Brachytherapy for Prostate Cancer: A Systematic Review by Georgios Koukourakis, Nikolaos Kelekis, Vassilios Armonis, Vassilios Kouloulias

“…Low-dose rate brachytherapy has become a mainstream treatment option for men diagnosed with prostate cancer because of excellent long-term treatment outcomes in low-, intermediate-, and high-risk patients. …”
Get full text

Secondary Circulating Prostate Cells Predict Biochemical Failure in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease by Nigel P. Murray, Eduardo Reyes, Nelson Orellana, Cynthia Fuentealba, Leonardo Bádinez, Ruben Olivares, José Porcell, Ricardo Dueñas

“…The presence of circulating prostate cells (CPCs) in men without evidence of BF may be useful to predict patients at risk for BF. …”
Get full text

The Role of Immunohistochemistry for AMACR/p504s and p63 in Distinguishing Prostate Cancer from Benign Prostate Tissue Samples in Botswana by Ramatlho P, Rugemalila MM, Tawe L, Pain D, Choga OT, Ndlovu AK, Koobotse MO, Lal P, Rebbeck TR, Paganotti GM, Narasimhamurthy M, Kyokunda LT

Subjects: “…prostate cancer…”
Get full text

Systematic Review of Focal Prostate Brachytherapy and the Future Implementation of Image-Guided Prostate HDR Brachytherapy Using MR-Ultrasound Fusion by M. Sean Peach, Daniel M. Trifiletti, Bruce Libby

“…Prostate Cancer…”
Get full text

HTA and Reimbursement Status of Metastatic Hormone‑Sensitive Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer, and Metastatic Castration-Resistant Prostate Cancer Treatments in Europe: A Patient Access Landscape Review by Goran Bencina, Elina Petrova, Demet Sönmez, Sonia Matos Pereira, Ioannis Dimitriadis, Stina Salomonsson

“…Recently, novel therapies have received regulatory approval with significant improvement in overall survival for metastatic castration-resistant prostate cancer, metastatic hormone-sensitive prostate cancer, and nonmetastatic castration-resistant prostate cancer. …”
Get full text

Transition zone-based prostate-specific antigen density for differentiating clinically significant prostate cancer in PI-RADS score 3 lesions by Yongming Jin, Fei Chen, Gang Xu, Chaogang Wei, Congsong Dong

Subjects: “…Prostate cancer…”
Get full text

The Current Role of Osteoclast Inhibitors in Patients with Prostate Cancer by Diomidis Kozyrakis, Dionyssios Paridis, Stefanos Perikleous, Konstantinos Malizos, Anastasios Zarkadas, Antonios Tsagkalis

“…Purpose. Prostate cancer (PCa) is one of the most frequently diagnosed malignancies worldwide. …”
Get full text

Glucose Metabolism of Human Prostate Cancer Mouse Xenografts by Hossein Jadvar, Xiankui Li, Antranik Shahinian, Ryan Park, Michel Tohme, Jacek Pinski, Peter S. Conti

“…We hypothesized that the glucose metabolism of prostate cancer is modulated by androgen. We performed in vivo biodistribution and imaging studies of [F-18] fluorodeoxyglucose (FDG) accumulation in androgen-sensitive (CWR-22) and androgen-independent (PC-3) human prostate cancer xenografts implanted in castrated and noncastrated male athymic mice. …”
Get full text

GILT stabilizes cofilin to promote the metastasis of prostate cancer by Dunsheng Han, Zhiming Wu, Cong Zhang, Ziwei Wei, Fan Chao, Xuefeng Xie, Jinke Liu, Yufeng Song, Xiaoming Song, Dingchang Shao, Shiyu Wang, Guoxiong Xu, Gang Chen

“…While the involvement of GILT in the development of various tumors has been demonstrated, the mechanisms underlying its regulation in prostate cancer (PCa) are not fully understood. In the present study, we confirmed that GILT was significantly upregulated in PCa and facilitated tumor metastasis. …”
Get full text

Malondialdehyde in benign prostate hypertrophy: a useful marker? by Rosaria Alba Merendino, Francesco Salvo, Antonella Saija, Giuseppe Di Pasquale, Antonio Tomaino, Paola Lucia Minciullo, Giuseppe Fraccica, Sebastiano Gangemi

Subjects: “…Benign prostate hypertrophy…”
Get full text

Prostate cancer with metastasis in the fibula. Presentation of a Case. by Horacio Suárez Monzón, Rolando Delgado Figueredo, Santiago Palacio Pérez

“…The result of new exams required an inter-consult with the Service of Urology, to obtain the diagnosis of prostatic adenocarcinoma. The revision of the national and international literature didn't report any similar case; the atypical localization of the metastasis is what led to the preparation of the case for its knowledge and diffusion, for what it can contribute to the experience of professionals specialized in orthopedics or urology.…”
Get full text

Prostate Cancer Incidence and Mortality in Barbados, West Indies by Anselm J. M. Hennis, Ian R. Hambleton, Suh-Yuh Wu, Desiree H.-A. Skeete, Barbara Nemesure, M. Cristina Leske

“…Prostate Cancer…”
Get full text

Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate by Edgar Linden-Castro, Marcela Pelayo-Nieto, Alejandro Alias-Melgar, Daniel Espinosa-Perezgrovas, Ivan Ramirez-Galindo, Gabriel Catalan-Quinto

“…Ductal adenocarcinoma of the prostate is a rare histological variant that only represents <1% of prostate tumors. …”
Get full text